Illumina Says New Products Will Revive Array Business in H2 '10

Illumina expects array sales to rise again in the second half of next year as the San Diego firm makes higher-density chips available with rare variation content culled from efforts like the 1000 Genomes Project.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories